Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03040778 · ClinicalTrials.gov registry record · Phase 3
Pentoxifylline and Tocopherol (PENTO) in the Treatment of Medication-related Osteonecrosis of the Jaw (MRONJ)
A Phase 3 study, sponsored by University of Washington.
- Active
- Registry status
- Phase 3
- Development phase
- 100
- Enrollment target
NCT03040778 is a Phase 3 study that is active but no longer recruiting, run by University of Washington. The registered enrollment target is 100 participants.
The verdict
NCT03040778, a Phase 3 study, is active but no longer recruiting, sponsored by University of Washington.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 3
- Development phase
- 100 participants
- Enrollment target
Study Summary
The overall purpose of this project is to answer the following clinical question: Among Medication-Related Osteonecrosis of the Jaw (MRONJ) patients, do those who are treated with the Pentoxifylline and Tocopherol (PENTO) regimen and standard of care, when compared to those treated with standard of care alone, have decreased areas of exposed bone after one year of treatment?
Interventions
- DRUG Placebo
- DRUG Pentoxifylline
- DRUG Tocopherol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2018-04-01 |
| Est. Completion | 2026-06-30 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03040778
The ClinicalTrials.gov registry entry for NCT03040778 describes a study currently listed as active not recruiting, categorized as Phase 3. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT03040778 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03040778 about?
NCT03040778 is a clinical study titled "Pentoxifylline and Tocopherol (PENTO) in the Treatment of Medication-related Osteonecrosis of the Jaw (MRONJ)". The overall purpose of this project is to answer the following clinical question: Among Medication-Related Osteonecrosis of the Jaw (MRONJ) patients, do those who are treated with the Pentoxifylline and Tocopherol (PENTO) regimen and standard of care, when compared to those treated with standard of ...
What is the current status of trial NCT03040778?
This trial is currently active not recruiting. It is a Phase 3 study. The enrollment target is 100 participants. The study started on 2018-04-01. Estimated completion is 2026-06-30.
What interventions are being tested in trial NCT03040778?
The interventions under investigation include: Placebo (DRUG), Pentoxifylline (DRUG), Tocopherol (DRUG).
Who is sponsoring clinical trial NCT03040778?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.